Profile马振坤博士 (Dr.Zhenkun Ma)
Founder and CEO, TenNor Therapeutics Limited
马振坤博士毕业于北京大学，先后获得化学学士与硕士学位。后赴美国康涅狄格大学深造并获得有机化学博士学位。博士毕业后于波士顿学院化学系任博士后研究员。马博士有三十多年的行业工作经验，曾先后就职于多家国际知名的医药企业及机构，如赛诺菲，雅培制药等。他于2004年加入非盈利组织TB Alliance (结核病联盟) 并担任首席科学家，专注于抗结核病的新药开发。马博士于2013年创立了专注于传染病新疗法的公司丹诺医药并担任首席执行官。
Dr. Zhenkun Ma obtained his Bachelor’s and Master’s degrees in Chemistry from Peking University. He obtained his PhD degree from University of Connecticut in Organic Chemistry. After graduation, he did his postdoctoral training at Boston College for two years before starting his career in pharmaceutical sciences. Dr. Zhenkun Ma has more than thirty years of experience in the pharmaceutical industry. He worked for several well-known enterprises including Sanofi and Abbott Laboratories. He also worked as the Chief Scientific Officer for the non-profit organization TB Alliance, focusing on the development of new drugs for tuberculosis. He founded his own company TenNor Therapeutics in Suzhou in 2013 with targets on the discovery and development of novel therapeutics for infectious diseases.